Background: There are many ways to synthesize new
Introduction
Drug-drug interaction is an important issue in clinical practice as well as in the discovery and development of new drugs. A large number of medications is used simultaneously that may increase the risks for drug interactions. The therapeutic effects of drugs may exhibit independently or may interfere or interact with each other.
The interaction may be agonist or antagonist of one drug by another.
Sometimes, multiple drug therapy is favorable to the patients and sometimes it causes serious adverse effects. Therefore, combinations of drugs chosen for investigation of drug-drug interactions are selected for alteration in the pharmacokinetics or pharmacodynamics of a narrow therapeutic index drug (Saha et al., 2013) . Thus the drug interaction study is very much important in respect to both biopharmaceutics and pharmacology (Goodman, 1996; Saha et al., 2015) . Andrographis paniculata (Burm. f.) Wall. Ex Nees belongs to the family of Acanthaceae which is called as Kalmegh or King of Bitters (Mishra, Sangwan, & Sangwan, 2007; Rajani, Shrivastava, & Ravishankara, 2000) . It is an herbaceous plant and is found in tropical and subtropical Asia, Southeast Asia, and India (Jarukamjorn & Nemoto, 2008) . It has wide range of pharmacological application, which has been used either single or in combination with other drugs in various Indian traditional systems of medicine like Ayurveda and Sidda. Traditionally, mostly leaves and roots are used for different medicinal purposes in Asia and Europe that is also known as folklore remedy or as herbal supplement for health promotion or ailments (Jarukamjorn & Nemoto, 2008) . It possesses several phytochemical constituents with unique and interesting biological properties.
The bioactive compound 'andrographolide' is one of the major components of the plant A. paniculata. Andrographolide is a highly bitter, colorless crystalline compound (Mishra et al., 2007) . Andrographolide is chemically described as 3 , 14, 15, 18-tetrahydroxy-5 , 9 H, 10 -labda-8, 12-dien-16-oic acid -lactone (Fig. 1A) . The melting point of this compound is 228 ºC-230 ºC and the ultraviolet spectrum in ethanol, λmax is 223 nm. Traditionally it is used in the treatment of gastro-intestinal tract and upper respiratory infections, fever, herpes, sore throat, and a variety of other chronic and infectious disease (Mishra et al., 2007) . In traditional Chinese medicine, it is a significant for cold property which is used to throw out the body-heat and to disperse toxins of the body (Deng, 1978; Jarukamjorn & Nemoto, 2008) . The Indian Pharmacopoeia reports that it is a predominant constituent of at least 26 Ayurvedic formulations (Jarukamjorn & Nemoto, 2008; Mishra et al., 2007; WHO media center, 2007) . It is commonly used for the prevention or treatment of cold in Scandinavian countries (Cáceres, Hancke, Burgos, & Wikman, 1997; Jarukamjorn & Nemoto, 2008) . Mirabegron is a potent β3-adrenoceptor agonist that is recently approved by Food and Drug Administration for the prospective treatment of overactive bladder therapy (Takasu et al., 2007) .
Suvorexant is a selective, dual orexin receptor antagonist and the first drug in its class to reach the market. IUPAC name of suvorexant (Fig. 1C ). It is a medication for the treatment of insomnia which is characterized by difficulties with sleep onset and/or sleep maintenance approved in the United States and Japan in late 2014 (Baxter et al., 2011; Patel, Aspesi, & Evoy, 2015; Sutton, 2015) . Some people reported that the drug caused a sleep disturbance such as a nightmare, sleep terror, or abnormal dream or to be more awake or even thoughts of suicide (Jacobson, Callander, & Hoyer, 2014; Teresa Carr, 2016) .
The principal purpose of the present study was to investigate complex formation for synthesizing new molecule with biological activity which could be due to interaction of andrographolide and suvorexant; andrographolide and mirabegron, and suvorexant and mirabegron.
Methods

Materials
Andrographolide, suvorexant and mirabegron were collected from authentic sources. HPLC grade methanol and chloroform were purchased from Sigma Aldrich, Germany. Nanopure water was used and collected from own source. The drug complexes of andrographolide, suvorexant and mirabegron were synthesized according to the calculated w/w ratio. The complexes were prepared by solid-mixing method using pestle and mortar by adding equal amount of drugs to each other, then warmed at 50 °C for 4 hours and left at room temperature for overnight to obtain new drug complexes of andrographolide-suvorexant, andrographolide-mirabegron, and suvorexant-mirabegron (Sultana, Arayne, Rizvi, Haroon, & Mesaik, 2013). 
Characterizations
Differential Scanning Calorimetry (DSC)
Complexes of the drugs were studied using DSC-60, Shimadzu Corporation, Japan. Sample was weighed and placed in a sealed aluminum pan and scanned from room temperature to 300 °C with heating rate of 10 °C/min. The DSC analyses were performed of pure andrographolide, suvorexant, mirabegron and their binary mixtures.
Fourier-transform infrared spectroscopy (FTIR) FTIR spectra of pure andrographolide, suvorexant, mirabegron and their binary complexes were recorded using KBr disk on FTIR spectro-photometer (IR prestige-21, Shimadzu, Japan).
Cytotoxicity study Cytotoxicity study was done against Hela cell line. Hela is a human cervical carcinoma cell line that was maintained in DMEM (Dulbecco's Modified Eagles' medium) containing 1% penicillinstreptomycin (1:1) and 0.2% gentamycin and 10% fetal bovine serum (FBS). HeLa Cells (2.010 4 /100 µL) were seeded onto 96-well plate and incubated at 37 o C+5% CO2 for 24 h. Later on, 100 µL of sample was added into each well and incubated for 48 h at 37 o C+5% CO2. Then cytotoxic effect was evaluated under inverted light microscope. Duplicate wells were used for each sample.
Results and Discussion
Thermal analysis by DSC The DSC thermograms of pure andrographolide, suvorexant, mirabegron and drug complexes are represented in Fig. 2A, Fig. 2B and Fig. 2C . From these figures it was found that the DSC thermogram of pure andrographolide showed a single endotherm peak at 230.87 °C which was ascribed to drug melting (Rajani et al., 2000) . The endothermic peak of pure mirabegron was also found at 140.40 °C (Patal & Patal, 2018) , and at 127.09 °C for the pure suvorexant which are correspond to the melting temperatures of the drugs respectively. The melting endothermic peaks of drug complexes like as andrographolide-suvorexant, andrographolidemirabegron, and suvorexant-mirabegron complexes were found at 221.02 °C, 189.49 °C and 115.78 °C, respectively which were different from the melting endotherms of andrographolide, suvorexant and mirabegron. Therefore, these different melting endotherms indicated the different compounds which were formed from interaction of the drugs each other.
Fourier-transform infrared spectroscopy (FTIR)
The FT-IR spectrum of the adrographolide (Fig. 3A) (Mohana & Umarani, 2016; Sajeeb, Kumar, Halder, & Bachar, 2015) . The spectrum of pure mirabegron (Fig. 3B) The FTIR spectrum of the complex compound of andrographis and mirabegron (Fig. 3A) 
Cytotoxic activity
The cytotoxic activity of the pure drugs (andrographolide, suvorexant, mirabegron) and drug complexes were quantified by exposure of these drugs to the specific cell lines. The cytotoxic activity of these drugs was examined against HeLa cell (Ferdous, Shishir, Khan, & Hoq, 2018; Vasanthabharathi & Jayalakshmi, 2018; Wu et al., 2017) . Higher concentrations (2.5 mg/dose) of each sample of andrographolide, suvorexant, mirabegron and drug complexes were used separately for their cytotoxicity test. After 48 hour incubation, it was observed that the cytotoxic activity of the drug complexes on HeLa cell line were higher (10% less survived HeLa cell, i.e. > 90 % cell died) than the precursor drug molecules (Table 1) .
Conclusion
The in vitro drug-drug interactions seem to positively change the beneficial effects on therapeutic outcomes, i.e. the complexes of andrographolide-suvorexant, andrographolide-mirabegron, and suvorexant-mirabegron showed different biological activities. In the discovery research phase to design new molecules, various in vitro and in vivo studies are required to determine the value of these new complexes to meet targeted medical needs. This research also indicated that concomitant intake of these drugs should attain more precautions.
